Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stance of MRD in Non-Hodgkin's Lymphoma and its upsurge in the novel era of cell-free DNA.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Nov 2021

Garg S, Kumar A, Gupta R

Abstract excerpt

Cancer genomics has evolved over the years from understanding the pathogenesis of cancer to screening the future possibilities of cancer occurrence. Understanding the genetic profile of tumors holds a prognostic as well as a predictive value in this era of therapeutic surveillance, molecular remission, and precision medicine. Identifying molecular markers in tumors is the current standard of approach, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell-Free Nucleic Acids
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liquid Biopsy

Share to Lymphoma

Share to Lymphoma, Non-Hodgkin

Share to Neoplasm, Residual

Share to Positron-Emission Tomography

Share to Translocation, Genetic

Source

Identifiers

PMID: 33991328
DOI: 10.1007/s12094-021-02635-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stance of MRD in Non-Hodgkin's Lymphoma and its upsurge in the novel era of cell-free DNA.PMID 33991328Read ↗

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNASemantic proximity Read ↗

Circulating tumor DNA: current challenges for clinical utility.Semantic proximity Read ↗

Circulating Tumor DNA in Lymphoma: Principles and Future DirectionsSemantic proximity Read ↗

Advances in Circulating Tumor DNA Analysis.Semantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Minimal Residual Disease Using Liquid Biopsies in Hematological MalignanciesSemantic proximity Read ↗

Cell-free DNA as a biomarker in cancerSemantic proximity Read ↗

Circulating Tumor DNA in Lymphoma.Semantic proximity Read ↗

Recent advances in circulating nucleic acids in oncologySemantic proximity Read ↗

Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature ReviewSemantic proximity Read ↗

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision MedicineSemantic proximity Read ↗

Application and optimization of minimally invasive cell-free DNA techniques in oncogenomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.